Active	Status	Sponsor type	Region	Phase	Filter
5 Active 1 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
bacteriophage therapy / BiomX
APT.DFO.001, NCT05177107: Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis	Recruiting	2b	126	US	Phage Therapy, Placebo	Adaptive Phage Therapeutics, Inc., United States Department of Defense	Osteomyelitis, Diabetic Foot Osteomyelitis	04/24	12/24
ACTIVE2, NCT05269134: Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)	Withdrawn	2	90	US	Bacteriophage, Placebo	Adaptive Phage Therapeutics, Inc.	Prosthetic Joint Infection	07/25	07/27
NCT04287478: Bacteriophage Therapy in Patients With Urinary Tract Infections	Terminated	1/2	1	US	Bacteriophage Therapy	Adaptive Phage Therapeutics, Inc., United States Department of Defense	Urinary Tract Infection Bacterial	02/23	02/23
ACTIVE1, NCT05269121: Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections	Withdrawn	1/2	20	NA	Phage Therapy	Adaptive Phage Therapeutics, Inc.	Prosthetic Joint Infection, Bacterial Infections	11/23	11/24
NCT05453578: A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa	Recruiting	1/2	72	US	Placebo, WRAIR-PAM-CF1	National Institute of Allergy and Infectious Diseases (NIAID)	Bacterial Disease Carrier, Cystic Fibrosis	12/24	12/24
Coronavirus Vaccine / BiomX
No trials found